Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose

This case series study examines the safety of second doses of messenger RNA COVID-19 vaccines after first-dose allergic reactions.

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Intern Med
Main Authors: Krantz, Matthew S., Kwah, Jason H., Stone, Cosby A., Phillips, Elizabeth J., Ortega, Gilbert, Banerji, Aleena, Blumenthal, Kimberly G.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2021
Assuntos:
Research Letter
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8314170/
https://ncbi.nlm.nih.gov/pubmed/34309623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2021.3779
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados